CClinicalTrials.gg
TerminatedNCT07231237Updated May 6, 2026

Clinical Study Evaluating Solventum™ Vitrebond™ Pulp Protect Liner/Base for Direct Capping of Pulpal Exposure

An interventional study of Vitrebond™ Pulp Protect Liner/Base in Dental Caries, Pulp Exposure, Dental and Tooth Decay, sponsored by Solventum US LLC. Terminated at 1 site in United States. Open to participants aged 7 Years to 89 Years. Per ClinicalTrials.gov, last updated 2026-05-06.

Sponsored by Solventum US LLC · Not applicable, Interventional, and Treatment

Why this study was terminated
The study was terminated early due to a business decision by the sponsor.
Phase
Not applicable
Study type
Interventional
Enrollment
5
Allocation
Not applicable
Ages
7 Years to 89 Years
Sex
All
01

Study summary

This research study is looking at the safety and effectiveness of Solventum™ Vitrebond™ Pulp Protect Liner/Base for direct pulp capping (DPC) on permanent teeth that have pulp exposure due either to deep cavities, trauma, or other accidental causes. Dental pulp is the part of the tooth that contains the nerves, blood vessels, and cells that keep teeth healthy. The DPC procedure is done by dentists to help preserve tooth health if there is pulp exposure during the tooth restoration or due to trauma. Participants must have at least one permanent tooth with pulp exposure that needs DPC to be eligible for the study.

Read the detailed description

This is a multi-site, single-arm, prospective clinical study evaluating Solventum™ Vitrebond™ Pulp Protect Liner/Base treatment for direct pulp capping on permanent teeth. Vitrebond™ Pulp Protect Liner/Base is a new product designed to be placed under dental fillings that can be used as a "Liner/Base" to create a lining between the tooth and the filling to reduce sensitivity, and for direct pulp capping if there is a small amount of dental pulp exposed during the restoration.

The purpose of this clinical study will be to assess the effectiveness and safety of Vitrebond™ Pulp Protect for direct pulp capping on permanent teeth that have pulp exposure due either to deep cavities, trauma, or other accidental causes. The primary objective is to evaluate Vitrebond™ Pulp Protect Liner/Base in maintaining pulp vitality (a measure of tooth health) when used for pulp capping, measured at 1-year post-restoration. The secondary objective of this study is to evaluate treated teeth for abnormal clinical signs or symptoms for up to 5 years after treatment to assess long-term safety and effectiveness. The success of Vitrebond™ Pulp Protect for direct pulp capping in this single-arm clinical study will be determined based on an assessment of pulp vitality one year after restoration compared to a pre-specified performance goal derived from literature using calcium hydroxide as the reference comparator.

02

Conditions studied

  • Dental Caries
  • Pulp Exposure, Dental
  • Tooth Decay
  • Dental Decay

Keywords

  • dental
  • caries
  • cavities
  • pulp exposure
  • direct pulp capping
  • Vitrebond Pulp Protect
  • pulp vitality
  • dentin bridge
  • pulp protection
03

In context

Dental Caries

1,109 studies on the registry are indexed under Dental Caries; 197 are open to participants now.

This study's enrollment of 5 is below the median of 60 across 916 interventional studies indexed under Dental Caries.

Browse Dental Caries studies →

Lead sponsor

Solventum US LLC is the lead sponsor of 62 studies on the registry; 2 are open to participants now.

Of its 18 completed or terminated interventional studies of FDA-regulated products, 16 (89%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
7 Years to 89 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Subject is age 7 years or older at time of consent.
  2. Subject is in good general health (i.e., meets American Society of Anesthesiologists (ASA) Level I or ASA Level II classification criteria).
  3. Subject or Subject's Legally Authorized Representative is able and willing to understand and sign an Informed Consent Form or give Assent, as applicable.
  4. Subject is able and willing to return in-person for all scheduled study visits.
  5. Subject is able and willing to follow study restrictions.
  6. Subject has existing dental radiographic images of the study teeth of current and acceptable diagnostic quality taken within 3 months of tooth restoration.
  7. Study tooth has healthy periodontal tissues or mildly inflamed tissues not associated with trauma, with probing depths no greater than 4 mm and no gingival recession associated with self-reported sensitivity.
  8. Study tooth has no pre-operative sensitivity or exhibit pre-operative sensitivity that is relieved immediately after stimulus removal.
  9. Study tooth has a positive response to a sensibility test (i.e., cold test using a refrigerant spray).
  10. Study tooth can be restored with a direct permanent restoration (stepwise caries removal will not be used).
  11. Study teeth are on opposite right/left sides of the mouth (for Subjects with more than one candidate study tooth).
  12. Study tooth will be restored no later than 1 month after the date of the first study tooth's restoration (for Subjects with more than one candidate study tooth).

    Intra-operative Inclusion Criteria:

  13. Subject has one or more permanent teeth with pinpoint pulpal exposure (0.5 mm - 1.0 mm in diameter) needing direct pulp capping, excluding third molars.

Exclusion criteria

Exclusion Criteria:

  1. Subject has a history of adverse reaction to any materials used in this study, including but not limited to acrylates.
  2. Subject is unable, for any reason, to tolerate the study procedures (e.g., use of a rubber dam) or the length of time required to complete the restoration(s) on the study tooth/teeth.
  3. Subject is taking part in or planning to be enrolled in a clinical evaluation of any other dental materials at any time during the study.
  4. Subject has a history of chronic use of anti-inflammatory, analgesic (pain), and/or mind-altering drugs for medical (including psychiatric) and pharmacotherapeutic therapies that might alter perception of pain.
  5. Subject is pregnant or breast feeding at the time of screening.
  6. Subject has any spontaneous or other orofacial pain (excluding pain from trauma cases, which may exhibit spontaneous pain due to tooth fracture) within the same quadrant as the study tooth that may interfere with assessment of sensitivity.
  7. Study tooth diagnosed with cracked tooth syndrome.
  8. Study tooth mobility >= grade 2 using the Miller's tooth mobility index.
  9. Study tooth has previous and current signs and symptoms of pulpal and/or periapical disease (e.g., root resorption or pulpal calcifications) or irreversible pulpitis (excluding pain from trauma cases).
  10. Study tooth has no systemic mineralization pathology (e.g., amelogenesis imperfecta, enamel hypoplasia, etc.)
  11. Study tooth that is not restorable
  12. Study tooth that requires a crown preparation.
  13. Subject is, in the opinion of the Investigator, unsuitable for enrollment in the study for reasons other than those specified in the above exclusion criteria.
  14. Study tooth has an existing restoration or requires a new restoration that interferes with radiographic assessments (e.g., caries on the buccal surface).

    Intra-operative Exclusion Criteria:

  15. Study tooth exhibits bleeding of the exposed pulp that does not stop within 8 minutes.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
5 participants (actual)

Study arms

  • Experimental
    Vitrebond™ Pulp Protect Liner/Base

    Vitrebond™ Pulp Protect Liner/Base used for Direct Pulp Capping

    Device: Vitrebond™ Pulp Protect Liner/Base

Interventions

  • DeviceVitrebond™ Pulp Protect Liner/Base

    Vitrebond™ Pulp Protect Liner/Base used for Direct Pulp Capping

06

What researchers measure

Primary outcomes

  1. Pulp Vitality at 1-year

    Pulp vitality, assessed by pulp sensibility testing using a refrigerant spray intended for dental use. A positive response from the pulp sensibility test is indicative of the pulp vitality of the tooth (primary endpoint). Categories for pulp vitality will include: 1. Vital pulp (normal): Positive response from the pulp sensibility test that subsides within 5 seconds. 2. Reversible pulpitis: Positive response from pulp sensibility test that lasts greater than 5 seconds up to approximately 30 seconds. 3. Irreversible pulpitis: Prolonged positive response from pulp sensibility test that lasts more than approximately 30 seconds. 4. Non-vital pulp: Negative response from the pulp sensibility test.

    Time frame: 1 year post-restoration

Secondary outcomes

  1. Pulp Vitality at baseline, 3 months, 6 months, and 2, 3, 4, and 5 years

    Pulp vitality, assessed by pulp sensibility testing using a refrigerant spray intended for dental use. A positive response from the pulp sensibility test is indicative of the pulp vitality of the tooth (primary endpoint). Categories for pulp vitality will include: 1. Vital pulp (normal): Positive response from the pulp sensibility test that subsides within 5 seconds. 2. Reversible pulpitis: Positive response from pulp sensibility test that lasts greater than 5 seconds up to approximately 30 seconds. 3. Irreversible pulpitis: Prolonged positive response from pulp sensibility test that lasts more than approximately 30 seconds. 4. Non-vital pulp: Negative response from the pulp sensibility test.

    Time frame: Baseline, 3 months, 6 months, and 2, 3, 4, and 5 years post-restoration.

  2. Reparative dentin formation

    Signs of reparative dentin formation assessed by bitewing (for posterior teeth) or periapical (for anterior teeth) radiographs taken at scheduled follow-up visits. Reparative dentin formation is desired. Categories for reparative dentin formation will include: 1. Presence of reparative dentin formation 2. Absence of reparative dentin formation

    Time frame: 6 months and 1 year, and only if taken at the 2-, 3-, 4-, and 5-year post-restoration

  3. Apical periodontitis

    Apical periodontitis will be assessed by the clinician based on clinical assessments of symptoms (percussion of teeth, palpation of nearby bone, and visual examination of tissues) as well as periapical radiographs taken at scheduled follow-up visits. Absence of apical periodontitis is desired. Categories for apical periodontitis (symptomatic and/or asymptomatic) formation will include: 1. Presence of apical periodontitis 2. Absence of apical periodontitis

    Time frame: 6-months and 1-year post-restoration, and at 2-, 3-, 4-, and 5-years post-restoration if periapical radiographs are taken

  4. Internal root resorption

    Internal root resorption will be assessed by periapical radiographs taken at each scheduled follow-up visit at 6 months and 1 year, and if taken at the 2-, 3-, 4-, and 5-year follow-up visits and any unscheduled visits involving study teeth. Absence of internal root resorption is desired. Categories for internal root resorption will include: 1. Presence of internal root resorption 2. Absence of internal root resorption

    Time frame: 6 months and 1 year, and if taken at the 2-, 3-, 4-, and 5-years post-restoration

  5. External root resorption

    External root resorption will be assessed by periapical radiographs taken at each scheduled follow-up visit at 6 months and 1 year, and if taken at the 2-, 3-, 4-, and 5-year follow-up visits and any unscheduled visits involving study teeth. Absence of external root resorption is desired. Categories for external root resorption will include: 1. Presence of external root resorptions 2. Absence of external root resorptions

    Time frame: 6 months and 1 year, and if taken at the 2-, 3-, 4-, and 5-years post-restoration

  6. Pulp canal obliteration

    Pulp canal obliteration will be assessed by periapical radiographs taken at each scheduled follow-up visit at 6 months and 1 year, and if taken at the 2-, 3-, 4-, and 5-year follow-up visits and any unscheduled visits involving study teeth. Absence of pulp canal obliteration is desired. Categories for pulp canal obliteration will include: 1. Presence of pulp canal obliteration 2. Absence of pulp canal obliteration

    Time frame: 6 months and 1 year, and if taken at the 2-, 3-, 4-, and 5-years post-restoration

  7. Pathological tooth mobility

    Pathological tooth mobility will be assessed by clinicians at scheduled visits. The American Academy of Periodontology definition of tooth mobility is the movement of a tooth in its socket resulting from an applied force. Categories for pathological tooth mobility using the Miller's tooth mobility index will include: 1. Class 0: normal (physiologic) movement when force is applied 2. Class 1: \< 1 mm (horizontal) a. mobility greater than physiologic 3. Class 2: ≥1 mm (horizontal), 1. tooth can be moved 1 mm or more in a lateral direction (buccolingual or mesiodistal); and 2. inability to depress the tooth in a vertical direction (apicocoronal) 4. Class 3: ≥1 mm (horizontal and vertical) 1. tooth can be moved 1 mm or more in a lateral direction (buccolingual or mesiodistal); and 2. ability to depress the tooth in a vertical direction (apicocoronal)

    Time frame: baseline, 3 months, 6 months, and 1, 2, 3, 4, and 5 years post-restoration

  8. Spontaneous pain

    Spontaneous pain not due to a stimulus will be self-assessed by subjects for each study tooth at scheduled visits. The baseline spontaneous pain assessment should be conducted a minimum of 3 hours after completing the restoration to allow time for the anesthesia to wear off. The baseline assessment may be conducted via phone to ask the subject if they are experiencing any spontaneous pain in the study tooth and must be completed within 1 week of the tooth restoration. The absence of spontaneous pain is desired. Spontaneous pain is defined as prolonged intense pain that doesn't respond to over-the-counter pain medication, and/or pain that wakes you up from sleep. Categories for spontaneous pain will include: 1. Presence of spontaneous pain 2. Absence of spontaneous pain

    Time frame: baseline, 3 months, 6 months, and 1, 2, 3, 4, and 5 years post-restoration

07

Study locations

1 site
  • Tufts University
    Boston, Massachusetts 02111, United States
08

References and documents

Publications

  • Miller, S.C, Textbook of periodontia, Blakiston Company, Philidelphia, 1938

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07231237
Lead sponsor
Solventum US LLC
Responsible party
Sponsor
First posted
Nov 17, 2025
Start date
Feb 17, 2026
Primary completion
Apr 15, 2026
Completion
Apr 15, 2026
Last update
May 6, 2026

Study contacts

Mabi Singh, DMD, BDS, MS
principal investigator · Tufts University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion